S-1-based combination therapy vs S-1 monotherapy in advanced gastric cancer:A meta-analysis
S-1-based combination therapy vs S-1 monotherapy in advanced gastric cancer:A meta-analysis作者机构:Department of Gastroenterology and HepatologySubei People’s Hospital of Jiangsu Province (Clinical Medical College of Yangzhou University) Department of Gastrointestinal SurgerySubei People’s Hospital of Jiangsu Province (Clinical Medical College of Yangzhou University)
出 版 物:《World Journal of Gastroenterology》 (世界胃肠病学杂志(英文版))
年 卷 期:2014年第20卷第1期
页 面:310-318页
核心收录:
学科分类:1002[医学-临床医学] 100214[医学-肿瘤学] 10[医学]
主 题:S-1 Advanced gastric cancer Meta-analysis Overall survival Chemotherapy
摘 要:AIM: To assess the efficacy and safety of combination therapy based on S-1, a novel oral fluoropyrimidine, vs S-1 monotherapy in advanced gastric cancer (AGC).